These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 804510

  • 1. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W, Schmidt G, Lynen R, Dieminger L.
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [Abstract] [Full Text] [Related]

  • 2. Proceedings: Cleavage of the third complement component (C3) and release of a spasmogenic, C3-derived peptide (C3a) by epsilon-aminocaproic acid (EACA) in serum: a process involving the complement activating properdin system.
    Vogt W, Schmidt G.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Feb; 282(Suppl):suppl 282:R103. PubMed ID: 4276668
    [No Abstract] [Full Text] [Related]

  • 3. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
    Vogt W, Schmidt G, Dieminger L, Lynen R.
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of C5 convertase by epsilon amino caproic acid (EACA): a limiting factor in the generation of C5a anaphylatoxin.
    Vallota EH.
    Immunology; 1978 Mar; 34(3):439-47. PubMed ID: 417019
    [Abstract] [Full Text] [Related]

  • 5. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 6. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V, Bentley C, Bitter-Suermann D, Hadding U.
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A, Kay BK, Lambris JD.
    J Immunol; 1996 Jul 15; 157(2):884-91. PubMed ID: 8752942
    [Abstract] [Full Text] [Related]

  • 8. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K, Schur PH, Ruddy S.
    Clin Exp Immunol; 1979 Jun 15; 36(3):408-14. PubMed ID: 114347
    [Abstract] [Full Text] [Related]

  • 9. Isolation and characterization of Guinea pig properidin.
    Nicholson A, Austen KF.
    J Immunol; 1977 Jan 15; 118(1):103-8. PubMed ID: 830742
    [Abstract] [Full Text] [Related]

  • 10. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
    Ruddy S, Austen KF, Goetzl EJ.
    J Clin Invest; 1975 Mar 15; 55(3):587-92. PubMed ID: 1167871
    [Abstract] [Full Text] [Related]

  • 11. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V, Lee GD, Nicholson A, Shin HS, Mayer MM.
    J Immunol; 1973 Nov 15; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 15; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 13. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A, Kato T, Horai S, Yokoo J, Kashiba S.
    Biken J; 1975 Dec 15; 18(4):193-204. PubMed ID: 1218074
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
    Adam C, Williams DG, Peters DK.
    Clin Exp Immunol; 1975 Nov 15; 22(2):240-8. PubMed ID: 813932
    [Abstract] [Full Text] [Related]

  • 15. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

  • 16. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
    Ziegler JB, Watson L, Goodkofsky I, Alper CA, Lepow IH.
    J Immunol; 1976 Jan 01; 116(1):75-9. PubMed ID: 812917
    [Abstract] [Full Text] [Related]

  • 17. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R, Gordon J, Stevenson G, Ramadori G, Zanker B, Hadding U, Bitter-Suermann D.
    Eur J Immunol; 1986 Jan 01; 16(1):7-11. PubMed ID: 3512275
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.
    Soter NA, Austen KF, Gigli I.
    J Immunol; 1975 Mar 01; 114(3):928-32. PubMed ID: 1167567
    [Abstract] [Full Text] [Related]

  • 19. Humoral immunostimulation. IV. Role of complement.
    Shearer WT, Atkinson JP, Frank MM, Parker CW.
    J Exp Med; 1975 Apr 01; 141(4):736-52. PubMed ID: 1168690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.